Clinical Trials Browser

Phase 2 × S 1 (combination) × Tumor-Agnostic × Clear all

NCT06693128 2026-01-28

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

Phase 2 Active not recruiting

Adenocarcinoma

NCT05237349 2024-01-05

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

Phase 2 Unknown

Neoplasm Metastasis